INMB vs TYL · rev $50.0K vs P/E 89, rev $1.26B
INmune Bio Inc (INMB) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
INMB currently screens at market cap $33.5M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the INMB and TYL stock pages for the full models.
Not investment advice.